IL110385A - Melanoma-inhibiting protein - Google Patents

Melanoma-inhibiting protein

Info

Publication number
IL110385A
IL110385A IL11038594A IL11038594A IL110385A IL 110385 A IL110385 A IL 110385A IL 11038594 A IL11038594 A IL 11038594A IL 11038594 A IL11038594 A IL 11038594A IL 110385 A IL110385 A IL 110385A
Authority
IL
Israel
Prior art keywords
iib
iia
protein
melanoma
htz
Prior art date
Application number
IL11038594A
Other languages
English (en)
Other versions
IL110385A0 (en
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Priority to IL154248A priority Critical patent/IL154248A/en
Publication of IL110385A0 publication Critical patent/IL110385A0/xx
Publication of IL110385A publication Critical patent/IL110385A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL11038594A 1993-07-20 1994-07-20 Melanoma-inhibiting protein IL110385A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL154248A IL154248A (en) 1993-07-20 1994-07-20 Antibody against melanoma-inhibiting protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4324247 1993-07-20

Publications (2)

Publication Number Publication Date
IL110385A0 IL110385A0 (en) 1994-10-21
IL110385A true IL110385A (en) 2003-12-10

Family

ID=6493222

Family Applications (2)

Application Number Title Priority Date Filing Date
IL154248A IL154248A (en) 1993-07-20 1994-07-20 Antibody against melanoma-inhibiting protein
IL11038594A IL110385A (en) 1993-07-20 1994-07-20 Melanoma-inhibiting protein

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL154248A IL154248A (en) 1993-07-20 1994-07-20 Antibody against melanoma-inhibiting protein

Country Status (14)

Country Link
US (1) US5770366A (xx)
EP (2) EP0710248B1 (xx)
JP (1) JP3435163B2 (xx)
CN (1) CN1056617C (xx)
AT (1) ATE185152T1 (xx)
AU (1) AU7531294A (xx)
CA (1) CA2167693C (xx)
DE (2) DE59408791D1 (xx)
DK (1) DK0710248T3 (xx)
ES (1) ES2139751T3 (xx)
GR (1) GR3032212T3 (xx)
IL (2) IL154248A (xx)
WO (1) WO1995003328A2 (xx)
ZA (1) ZA945278B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653358A1 (de) * 1996-12-20 1998-06-25 Boehringer Mannheim Gmbh Immunoassay zum Nachweis von MIA
JP2001509029A (ja) * 1997-01-21 2001-07-10 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ヒトタンパク質
USRE39920E1 (en) 1997-05-30 2007-11-13 Xenomics, Inc. Methods for detection of nucleic acid sequences in urine
US6492144B1 (en) * 1997-05-30 2002-12-10 Diagen Corporation Methods for detection of nucleic acid sequences in urine
EP0945507A1 (de) * 1998-03-27 1999-09-29 Boehringer Mannheim Gmbh Tumorspezifische Expressionskontrollregion und deren Verwendung
US20020103360A1 (en) * 1998-09-01 2002-08-01 Yang Pan Novel protein related to melanoma-inhibiting protein and uses thereof
US20030072767A1 (en) * 1998-09-30 2003-04-17 Alexander Gaiger Compositions and methods for WT1 specific immunotherapy
EP1025871A1 (en) * 1999-01-28 2000-08-09 F. Hoffmann-La Roche Ag Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
US6713293B1 (en) * 1999-02-08 2004-03-30 Friedrich Grummt Encapsulated cells containing an amplified expression vector as a drug delivery device
CN1359421A (zh) 1999-06-30 2002-07-17 武田药品工业株式会社 新型多肽及其dna
WO2001055332A2 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
EP1133994A1 (en) * 2000-03-11 2001-09-19 Biognostik Gesellschaft für biomolekulare Diagnostik mbH A method for reversing the immunosuppressive effects of the Melanoma Inhibitory Activity "MIA"
PL358132A1 (en) * 2000-03-23 2004-08-09 Akzo Nobel N.V. Use of mia in immunotherapy
US6613534B2 (en) 2001-03-20 2003-09-02 Wake Forest University Health Sciences MAP-2 as a determinant of metastatic potential
US20100212037A1 (en) * 2002-10-16 2010-08-19 Anja Katrin Bosserhoff Mia-2 protein
CA2659270A1 (en) * 2006-07-28 2008-01-31 Novartis Ag Use of melanoma inhibitory activity (mia) protein as an early indicator for therapeutic response in melanoma
ES2660785T3 (es) * 2007-08-22 2018-03-26 Trovagene, Inc. Métodos de uso de ARNmi para la detección de la muerte de células in vivo
WO2011134979A2 (en) 2010-04-27 2011-11-03 Scil Technology Gmbh Stable mia/cd-rap formulation
CN103025875A (zh) * 2010-08-30 2013-04-03 霍夫曼-拉罗奇有限公司 原核表达构建体
ITRM20110134A1 (it) * 2011-03-22 2012-09-23 Matteo Bordignon Inibitori di mia (attività inibitoria melanoma) per identificare, prevenire e curare la vitiligine

Also Published As

Publication number Publication date
WO1995003328A3 (de) 1995-03-16
EP0710248A1 (de) 1996-05-08
US5770366A (en) 1998-06-23
EP0947583A2 (de) 1999-10-06
WO1995003328A2 (de) 1995-02-02
CN1133049A (zh) 1996-10-09
DE59408791D1 (de) 1999-11-04
EP0947583A3 (de) 2000-05-03
DE4425481A1 (de) 1995-03-02
ES2139751T3 (es) 2000-02-16
GR3032212T3 (en) 2000-04-27
CN1056617C (zh) 2000-09-20
JP3435163B2 (ja) 2003-08-11
EP0710248B1 (de) 1999-09-29
CA2167693A1 (en) 1995-02-02
ATE185152T1 (de) 1999-10-15
ZA945278B (en) 1996-01-19
AU7531294A (en) 1995-02-20
CA2167693C (en) 2007-01-30
IL154248A (en) 2008-08-07
DK0710248T3 (da) 2000-04-10
IL154248A0 (en) 2003-09-17
JPH09500531A (ja) 1997-01-21
IL110385A0 (en) 1994-10-21

Similar Documents

Publication Publication Date Title
GR3032212T3 (en) Melanoma-inhibiting protein
ZA200005843B (en) New nucleotide sequences which code for the pck gene.
GR940300052T1 (en) Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
AU2795292A (en) Synthetic dna sequence having enhanced insecticidal activity in maize
HK1004150A1 (en) Calcium free subtilisin mutants.
CA2204257A1 (en) Tripeptidyl aminopeptidase
CA2102702A1 (en) Vitamin K-Dependent Carboxylase
CA2252493A1 (en) .beta.-galactoside - .alpha. 2,6-sialyltransferase gene
EP0479071A3 (en) Polypeptide
IL141869A0 (en) Mammalian transforming growth factor beta-9 (ztgfss9)
CA2191222C (en) Dna encoding the bacillus licheniformis pwd-1 keratinase
AU2898995A (en) Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant
AU7949991A (en) Cloned n-methylhydantoinase
CA2301902A1 (en) Novel extracellular serine protease
CA2155332A1 (en) Polypeptide having cold-stable pyruvate, orthophosphate dikinase activity, dna encoding the same and recombinant vector and transformed plants containing the dna
CA2144601A1 (en) Recombinant type ii collagenase from clostridium histolyticum and its use for isolating cells and groups of cells
ES2179760A1 (es) Genes codificantes de beta-agarasas y su utilizacion para producir enzimas de biodegradacion de agares.
AU5637298A (en) Novel cytochrome P450 gene
ES8700694A1 (es) Un procedimiento para producir un polipeptido de interferon hibrido antivirico y antiproliferante
EP0477791A3 (en) Polypeptide
ATE398681T1 (de) Nukleotidsequenzen die für das mene-gen kodieren
MX9605473A (es) Polipeptido hk2 recombinante.
ES2023538A6 (es) Procedimiento de obtencion y purificacion del fragmento carboxilo-terminal de la dna polimerasa i de streptococcus pneumoniae

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HP Change in proprietorship

Owner name: SCIL TECHNOLOGY GMBH.

Free format text: FORMER OWNER:ROCHE DIAGNOSTICS GMBH

KB Patent renewed
KB Patent renewed
EXP Patent expired